PV is a subtype of myeloproliferative neoplasms, characterized by an overproduction of red blood cells.[2] As demonstrated in the present case, almost all patients with PV have JAK2 V617F mutations. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.